Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE2812.00-52.45 (-1.83 % )
PREV CLOSE (Rs.) 2864.45
OPEN PRICE (Rs.) 2851.00
BID PRICE (QTY) 2810.15 (12 )
OFFER PRICE (QTY) 2813.00 (21 )
VOLUME 24888
TODAY'S LOW / HIGH (Rs.)2755.00 2860.00
52 WK LOW / HIGH (Rs.)422.25 3724.5
NSE2819.45 -42.85 (-1.5 % )
PREV CLOSE(Rs.) 2862.30
OPEN PRICE (Rs.) 2860.00
BID PRICE (QTY) 2819.45 (2718 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 151977
TODAY'S LOW / HIGH(Rs.) 2752.30 2860.00
52 WK LOW / HIGH (Rs.)421 3719

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.07
TTM EPS (Rs.) 80.32
P/E Ratio 35.01
Book Value (Rs.) 298.21
Face Value (Rs.) 10
MCap (Rs. in Mn) 65519.60
Price/Earning (TTM) 27.94
Price/Sales (TTM) 3.76
Price/Book (MRQ) 9.43
PAT Margin (%) 8.30
ROCE (%) 21.29
Incorporation Year : 1984

Management Info :

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office :

Address : Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone :

Email : NA

Website : www.aartidrugs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
01Sep09-01-2020$Allotment of Equity Shares Allotment of Equity Shares
Bonus issue Inter alia, has approved the following subject to approval of the Shareholders (through Postal Ballot and e-voting): a) Increase in authorized share capital of the Company from Rs. 25,00,00,000/- (Rupees Twenty Five Crore) to Rs. 120,00,00,000/- (Rupees One hundred and Twenty Crores) by creation of additional 9,50,00,000 (Nine Crores Fifty Lakhs) Equity Shares of Rs. 10/- (Rupees Ten only) each and consequent amendment to clause V of the Memorandum of Association of the Company. b) the issuance of fully paid up Bonus Share in the ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs. 10/- each for 1 (One) fully paid up Equity Share of Rs. 10/- each. The Company will intimate the ?Record Date? for determining eligible Shareholders entitled to receive Bonus Shares in due course
Bonus issue Inter alia, has approved the following subject to..
01Sep09-01-2020$Result of Postal Ballot Result of Postal Ballot
Bonus issue Inter alia, has approved the following subject to approval of the Shareholders (through Postal Ballot and e-voting): a) Increase in authorized share capital of the Company from Rs. 25,00,00,000/- (Rupees Twenty Five Crore) to Rs. 120,00,00,000/- (Rupees One hundred and Twenty Crores) by creation of additional 9,50,00,000 (Nine Crores Fifty Lakhs) Equity Shares of Rs. 10/- (Rupees Ten only) each and consequent amendment to clause V of the Memorandum of Association of the Company. b) the issuance of fully paid up Bonus Share in the ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs. 10/- each for 1 (One) fully paid up Equity Share of Rs. 10/- each. The Company will intimate the ?Record Date? for determining eligible Shareholders entitled to receive Bonus Shares in due course
Bonus issue Inter alia, has approved the following subject to..
17Aug08-17-2020$Aarti Drugs board to consider bonus issue Aarti Drugs board to conside

Aarti Drugs has informed that the Board Meeting of the Board of Directors of the Company is scheduled to be held on August 20, 2020 to consider a proposal for issue of Bonus Shares. In pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, read with Company’s Code on prohibition of Insider Trading, the Company is closing the ‘Trading Window’ with immediate effect and it will remain closed until August 22, 2020 for the aforesaid purpose.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that the Board Meeting of the Board of..
07Feb02-07-2020$Aarti Drugs fixes record date for interim dividend Aarti Drugs fixes record dat

Aarti Drugs has informed that the Board of Directors of the Company at its Meeting held on Thursday, February 6, 2020, has declared the Interim Dividend at the rate of Rs 2 (20%) per Equity share for the financial year 2019-20. As per Regulation 42(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed February 18, 2020 as the Record Date for the purpose of Payment of Interim Dividend.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that the Board of Directors of the Com..
30Jan01-30-2020$Aarti Drugs informs about board meeting Aarti Drugs informs about bo

Aarti Drugs has informed that the meeting of the Board of Directors of the Company is scheduled to be held on February 06, 2020, to consider, approve and take on record Audited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31, 2019, and consider and declare Interim Dividend for the FY 2019-20, if any.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs has informed that the meeting of the Board of Direc..
Financials More
Rs. in Millions
QTR Jun 20 ANNUAL 20
Net Profit730.31356.7
Gross Profit 990.3 1749.7
Operating Profit 1173.42454.6
Net Sales 4755.516349.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Advanced Enzyme (BSE)
 272.80 (19.99%)
M.Cap ( in Cr)
3046.59
Hester Biosciences (BSE)
 1744.95 (1.01%)
M.Cap ( in Cr)
1484.41
Alembic Pharma (BSE)
 926.00 (1.13%)
M.Cap ( in Cr)
18201.75
Panacea Biotec (BSE)
 196.80 (4.99%)
M.Cap ( in Cr)
1205.41
Suven Pharma (BSE)
 742.20 (0.93%)
M.Cap ( in Cr)
9446.91
Shareholding Pattern More
PROMOTERS 60.51 %
MUTUAL FUNDS/UTI 4.49 %
NON-INSTITUTION 32.58 %
FI/BANKS/INSURANCE 0.03 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes